Literature DB >> 9971827

Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells.

E Hatada1, S Saito, R Fukuda.   

Abstract

A short model genome RNA and also the genome RNA of influenza A virus bearing both 5'- and 3'-terminal common sequences activated the interferon-induced double-stranded-RNA-dependent protein kinase, PKR, by stimulating autophosphorylation in vitro. The activated PKR catalyzed phosphorylation of the alpha subunit of eucaryotic translation initiation factor 2 (eIF2alpha). The NS1 protein efficiently eliminated the PKR-activating activity of these RNAs by binding to them. Two mutant NS1 proteins, each harboring a single amino acid substitution at different regions, exhibited temperature sensitivity in their RNA binding activity in the mutant virus-infected cell lysates as well as when they were prepared as fusion proteins expressed in bacteria. The virus strains carrying these mutant NS1 proteins exhibited temperature sensitivity in virus protein synthesis at the translational level, as reported previously, and could not repress the autophosphorylation of PKR developing during the virus growth, which is normally suppressed by a viral function(s). As a result, the level of eIF2alpha phosphorylation was elevated 2.5- to 3-fold. The defect in virus protein synthesis was well correlated with the level of phosphorylation of PKR and eIF2alpha.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971827      PMCID: PMC104489     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase.

Authors:  T G Lee; J Tomita; A G Hovanessian; M G Katze
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

Review 2.  The war against the interferon-induced dsRNA-activated protein kinase: can viruses win?

Authors:  M G Katze
Journal:  J Interferon Res       Date:  1992-08

3.  Interactions between double-stranded RNA regulators and the protein kinase DAI.

Authors:  L Manche; S R Green; C Schmedt; M B Mathews
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  Binding of influenza A virus NS1 protein to dsRNA in vitro.

Authors:  E Hatada; R Fukuda
Journal:  J Gen Virol       Date:  1992-12       Impact factor: 3.891

5.  Specific binding of influenza A virus NS1 protein to the virus minus-sense RNA in vitro.

Authors:  E Hatada; T Takizawa; R Fukuda
Journal:  J Gen Virol       Date:  1992-01       Impact factor: 3.891

Review 6.  Interferon-induced proteins and the antiviral state.

Authors:  P Staeheli
Journal:  Adv Virus Res       Date:  1990       Impact factor: 9.937

7.  NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells.

Authors:  J C Richardson; R K Akkina
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Purification of double-stranded RNA-dependent protein kinase from mouse fibroblasts.

Authors:  C E Samuel; G S Knutson; M J Berry; J A Atwater; S R Lasky
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

9.  Analysis of influenza A virus temperature-sensitive mutants with mutations in RNA segment 8.

Authors:  E Hatada; M Hasegawa; K Shimizu; M Hatanaka; R Fukuda
Journal:  J Gen Virol       Date:  1990-06       Impact factor: 3.891

10.  Influenza A virus in vitro transcription: roles of NS1 and NP proteins in regulating RNA synthesis.

Authors:  R Skorko; D F Summers; J M Galarza
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

View more
  80 in total

Review 1.  Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor.

Authors:  R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 2.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

Review 3.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

4.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity.

Authors:  T Zürcher; R M Marión; J Ortín
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus.

Authors:  T Aragón; S de la Luna; I Novoa; L Carrasco; J Ortín; A Nieto
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

8.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice.

Authors:  Nicola R Donelan; Christopher F Basler; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors.

Authors:  Stephan Ludwig; Xiuyan Wang; Christina Ehrhardt; Hongyong Zheng; Nicola Donelan; Oliver Planz; Stephan Pleschka; Adolfo García-Sastre; Gudrun Heins; Thorsten Wolff
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.